An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease

William J. Sandborn*, Stephen Hanauer, Edward V. Loftus, William J. Tremaine, Sunanda Kane, Russell Cohen, Karen Hanson, Therese Johnson, Debra Schmitt, Resa Jeche

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

265 Scopus citations

Fingerprint

Dive into the research topics of 'An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences